A phase 2 trial of NRS-033 in patients with Opioid use disorder and alcohol use disorder
Latest Information Update: 25 Dec 2024
Price :
$35 *
At a glance
- Drugs NRS 033 (Primary)
- Indications Alcohol-related disorders; Opioid-related disorders
- Focus Therapeutic Use
- 25 Dec 2024 New trial record